100 000 dollars, c’est le prix pour lequel la Silicone Valley est en train de vaciller ! C’est le coup que coûte désormais le visa tech H-1B qui permet aux talents étranger de venir travailler aux États-Unis. Quel en sera l’impact et qui est-ce que ça va toucher ? C'est ce que vous allez découvrir dans ce nouvel épisode de Vitamine Tech !🧏[Transcription de l'épisode]🦻 ❤️Abonnez-vous sur vos apps et plateformes audio préférées 👉 🔊 Abonnez-vous à la newsletter podcast de Futura 👉 À

Discover how forgiveness through positive humanism promotes personal flourishing and emotional freedom within a secular worldview.

Guest: Alexis Leonard Sickle cell disease management traditionally involves two primary treatment approaches: disease-modifying therapies and curative strategies. While disease-modifying therapies can help reduce complications associated with the disease, they do not correct or fix them, which is why curative strategies are appealing to some patients and physicians. Join Dr. Alexis Leonard as she discusses the current management landscape for sickle cell disease, including

Guest: Alexis Leonard CRISPR technology, while relatively new, has shown potential in treating patients with sickle cell disease by increasing fetal hemoglobin. Though this gene therapy comes with safety considerations, refinements and advancements in CRISPR technology can offer new management options for sickle cell disease patients. Learn about the history of CRISPR as a sickle cell disease treatment and the future of this strategy with Dr. Alexis Leonard, who works in the Department

Guest: David Jacobsohn Gene therapy is redefining the treatment landscape for sickle cell disease, with approaches like gene addition, gene editing, and fetal hemoglobin induction showing promise in reducing or even eliminating symptoms. However, while these therapies offer some advantages over allogeneic stem cell transplant, they also come with significant challenges. In a conversation with Ryan Quigley, Dr. David Jacobsohn discusses considerations for these therapeutic approaches

Guest: Alexis Leonard With two FDA-approved gene therapies, including the first CRISPR-based treatment, curative strategies for sickle cell disease are continuing to expand the treatment landscape. However, challenges remain in optimizing safety and accessibility, particularly for patients unable to tolerate current myeloablative conditioning. Learn about advancements in ex vivo editing, such as improved stem cell targeting and multiplex editing, and the possibility of in vivo

人类已有的绝大部分结论均依赖于认识世界的工具，但不要忘记每个人最大的工具是自己的大脑。

Walter Willett, Shakuntala Thilsted and Johan Rockström discuss the second EAT-Lancet Commission report.

Show notes at pharmacyjoe.com/episode1064. In this episode, I’ll discuss “Do Not Crush” medication lists.The post 1064: Pharmacist’s Letter Fills the Gap Left by ISMP with a Do Not Crush List appeared first on Pharmacy Joe.

Big sagebrush (Artemisia tridentata) is a foundational species in the ecology and economy of much of western North America. It also faces numerous threats. From invasive grasses and mega wildfires, it is important that we learn how to better restore sagebrush and the habitat it provides. That is where people like Dr. Trevor Caughlin come in. Join us as we look at how he and his lab are leveraging new technologies to help understand sagebrush and move the needle on helping to restore it. This episode

In this episode, Dr Ailish Nimmo discusses appraisals with Dr Alex Hodsman. They discuss how appraisals fit into the revalidation system, Dr Hodsman's experience as an appraiser and what to consider when preparing for an appraisal meeting. Dr Alex Hodsman is a Consultant Nephrologist with a subspecialist interest in Renal Supportive Care. She is also an Educational Supervisor and has been a Consultant Appraiser for 10 years. Dr Ailish Nimmo is a Consultant working in Bristol and member of the

Shirin Lafiya Jari Ce tare da Azima Bashir Aminu  ya mayar da hankali yadda wasu alƙaluman baya-bayan nan a jihar Kaduna ta Najeriya ke nuna yadda ake samun ƙaruwar matan da ke mutuwa yayin goyon ciki ko haihuwa, wanda ke da nasaba da yadda jama’a ke ƙauracewa asibitoci walau a lokacin awo ko kuma haihuwa, wannan shi ne maudu’inmu na wannan mako sai ku biyomu. Wani binciken baya-bayan nan ya gano cewa matsalar ta mace-macen mata masu juna biyun tafi ta’azzara a ƙananan hukumomin jihar ta Kaduna guda

El 28 de mayo de 2025 celebramos el seminario "Acción feminista frente a la escalada bélica":https://www.hegoa.ehu.eus/es/events/77, la primera sesión del Seminario Permanente sobre Feminismos, Conflictos y Derechos Humanos. Este pódcast recoge las respuestas a las inquietudes que pudimos plantear a las ponentes de esta sesión: Sanja Pavlovic, de Mujeres de Negro de Belgrado (Serbia); María Villellas, de la Escola de Cultura de Pau (Universitat Autónoma de Barcelona); Ana Ribacoba, de la

Graham Laycock introducing Rachel Dutton from the Guildford Astronomical Society and Fellow of the Royal Astronomical Society featuring the latest developments in Astronomy and Space plus Astrocast looking at what to watch for in the coming month, Target of the Month and news of forthcoming local events.